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摘 要 
目的 
近年来，我国急性肝损伤的发病率呈逐年上升趋势，严重威胁人们健康。已
有的报道表明 IL-6 与急性肝损伤密切相关，但是 IL-6 在急性肝损伤中的功能尚
未完全明确。IL-6 的生物学功能具有多样性，它在炎症反应当中扮演着复杂的作
用，既起着促炎，也起着抗炎的作用。IL-6 的大多数促炎作用归因于反式信号转
导通路，而抗炎和再生信号传导，包括肝脏的急性期抗菌反应，均由 IL-6 经典
传导通路介导。本研究的目的就是明确 IL-6 在急性肝损伤所起到的作用，同时
进一步探讨相关机制研究。希望能为急性肝损伤的临床治疗和预防提供新思路及
新理论。 
方法 
在体动物实验：随机将 C57BL/6 小鼠分为：对照组，IL-6 组，LPS/D-GalN
诱导模型组，IL-6+LPS/D-GalN 诱导模型组，在不同的时间窗口（2h，6h）收取
血浆、肝脏组织。观察各组小鼠肝脏大体观、重量及 HE 染色变化，利用微板法
检测各组小鼠血浆中的谷丙转氨酶（ALT）、谷草转氨酶（AST）,用 RT-PCR
检测各组肝脏炎症因子 mRNA 水平表达的差异以及用酶联免疫吸附试验
（ELISA）检测血浆中炎症蛋白表达量的差异，用 TG 酶法检测肝脏中甘油三酯
含量。 
体外细胞实验：经 IL-6 重组蛋白预处理后，使用的不同浓度梯度 LPS 刺激
原代肝细胞、巨噬细胞系 RAW264.7 和原代巨噬细胞，通过 RT-PCR 检测 iNOS、
TNF-α、RANTES 等 M1 型 marker 基因 mRNA 水平的表达差异，利用酶联免疫
吸附试验（ELISA）检测巨噬细胞上清中炎症蛋白的表达水平变化，同时利用收
集的巨噬细胞上清培养小鼠原代肝细胞，用 RT-PCR 检测各种炎症因子 mRNA
水平表达的差异。 
结果 
1、我们摸索了用 LPS/D-GalN 注射诱导小鼠急性肝损伤模型的最佳使用浓
度为 LPS (50 μg/kg)/D-GalN (400 mg/kg)。 
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2、在 2 小时的时间点，4 组小鼠的肝脏外观正常，无明显区别。在 6 小时
的时间点，LPS/D-GalN 诱导模型组对比对照组，小鼠的肝脏外观肿胀、明显充
血，可呈现紫黑色，肝指数明显升高。提前给予 IL-6 的模型组小鼠对比模型组
小鼠，小鼠的肝脏外观肿胀、充血明显减轻，肝指数明显下降。 
3、在 2小时的时间点，小鼠肝组织 HE 染色结果显示，LPS/D-GalN 组对比
对照组小鼠，肝细胞肿胀，肝小叶结构轻微破坏。而 IL-6 预处理后，肝细胞肿
胀程度减轻，肝小叶正常结构得以重塑。在 6 小时的时间点，LPS/D-GalN 诱导
模型组对比对照组小鼠，肝小叶正常结构发生明显破坏，可观察到弥漫性肝组织
碎片状出血及坏死，大量炎性细胞浸润。提前给予 IL-6 预处理后，其肝脏损伤
明显减轻。 
4、在 2小时、6小时的时间点，LPS/D-GalN 诱导模型组对比对照组小鼠，
小鼠血浆中 ALT、AST 均明显升高。提前给予 IL-6 的模型组小鼠血浆中 ALT、
AST 的水平显著低于模型组小鼠。 
5、在 2小时、6小时的时间点，LPS/D-GalN 诱导模型组对比对照组小鼠，
小鼠的肝脏中炎症因子的 mRNA 表达水平和血浆中炎症因子的蛋白水平均明显
升高。而经 IL-6 预处理后，小鼠肝脏中炎症因子的 mRNA 表达水平和血浆中炎
症因子的蛋白水平显著下降。 
6、浓度为 1000 ng/ml 的 LPS 刺激肝细胞后，对比 PBS 组，肝细胞中炎症因
子（TNF-α、MCP-1）在 mRNA 水平表达有统计学意义的升高，其余浓度均未引
起炎症因子表达显著性变化。而 IL-6 联合 LPS 组对比 LPS 组，肝细胞中炎症因
子 mRNA 水平表达无明显差异。 
7、不同浓度的 LPS 对比 PBS 刺激不同来源巨噬细胞，M1 型炎症因子 mRNA
的表达呈现剂量依赖性升高, RAW264.7 细胞上清液中炎症蛋白表达水平明显增
多。而经 IL-6 预处理后，两种细胞中 M1 型炎症因子的 mRNA 表达水平显著下
降, RAW264.7 细胞上清中的炎症蛋白表达量显著下降。而以固定 LPS 浓度刺激
巨噬细胞，经不同浓度梯度 IL-6 预处理后，M1 型炎症因子的 mRNA 表达水平
呈剂量依赖性降低，具有显著性。 
8、用不同浓度的LPS培养巨噬细胞的上清液对比PBS组的上清培养肝细胞，
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肝细胞的炎症因子 mRNA 的表达水平呈剂量依赖性升高。经 IL-6 和 LPS 预处理
的巨噬细胞上清液，对比 LPS 组上清液培养肝细胞后，肝细胞中的炎症因子
mRNA 的表达水平显著下降。 
9、IL-4 或 IL-13 刺激巨噬细胞，对比 Vehicle 组，巨噬细胞中 M2 型炎症因
子（Arg-1,Mrc-1）在 mRNA 水平表达明显升高。而 IL-6 联合 LPS 组，对比 LPS
组，巨噬细胞中 M2 型炎症因子（Arg-1,Mrc-1）的 mRNA 表达水平显著升高，
同时 IL6 组的 IL-4R 和 IL-10 的 mRNA 表达显著高于 Vehicle 组。 
结论 
我们通过在不同时间点（2h，6h）对 C57BL/6 小鼠联合注射不同浓度的 LPS
和 D-GalN，诱导建立不同程度的急性肝损伤模型，并综合各项肝损伤指标筛选
出了 LPS 和 D-GalN 的最佳使用剂量（50 μg/kg, 400 mg/kg）。在此模型基础上，
IL-6 重组蛋白预处理显著缓解了 LPS/D-GalN 诱导的小鼠急性肝损伤，主要表现
为肝脏淤血程度的减轻、肝细胞肿胀的减少、肝小叶结构紊乱的逆转和血浆中肝
功能指标 ALT、AST 表达量的明显降低。在 LPS/D-Gal 诱导的急性肝损伤模型
中，炎症的发生扮演着重要作用。LPS 刺激肝脏内巨噬细胞后，促使大量炎症因
子的释放，炎症因子如 TNF-α 等进一步促进肝细胞凋亡和坏死，最终引起肝组
织损伤。我们的结果显示 IL-6 还能显著降低 LPS/D-GalN 诱导的急性肝损伤小鼠
肝脏中的炎症因子 mRNA 表达水平和血浆中炎症蛋白表达量，表现出对炎症反
应的抑制作用。 
我们在体外实验中发现，LPS 作用于肝实质细胞后只能引起微弱的炎症反
应，且 IL-6 对该炎症反应没有表现出调控作用。LPS 刺激各不同来源的巨噬细
胞后均可引起炎症因子的表达明显升高，且 IL-6 对不同浓度梯度 LPS 诱导的
M1 型巨噬细胞炎症因子 mRNA 和炎症蛋白的表达均有显著的抑制作用。IL-6
也可促进 IL-4 或 IL-13 诱导的巨噬细胞 M2 型极化。经 LPS 预处理后的巨噬细
胞上清液作用于肝细胞，可引起肝细胞炎症反应，而经 IL-6 和 LPS 同时预处理
后的巨噬细胞上清液对肝细胞炎症的诱导程度明显降低。显示 LPS 刺激巨噬细
胞释放大量的炎症因子，进一步作用于肝细胞，导致肝细胞炎症的发生，而 IL-6
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能通过抑制 LPS 诱导的 M1 型巨噬细胞的炎症因子的释放，抑制肝细胞炎症的
发展。 
关键词：急性肝损伤，白介素-6，脂多糖+D-半乳糖胺，巨噬细胞，炎症因子 
厦
门
大
学
博
硕
士
论
文
摘
要
库
Abstract 
V 
Abstract 
Objection 
In recent years, the incidence of acute liver injury in China was increasing year 
by year. This is a serious threat to human health. IL-6 has a variety of biological 
function and it plays a complex role in the inflammatory response. IL-6 has 
pro-inflammatory and anti-inflammatory effects. Most of the pro-inflammatory effects 
of IL-6 are due to trans-signal transduction pathways, whereas IL-6 classical 
transduction pathways mediate anti-inflammatory and regenerative signaling. 
Previous reports have shown that IL-6 is relevant to acute liver injury, but the role of 
IL-6 in acute liver injury is not well defined. Therefore, the purpose of our study is to 
clarify the role of IL-6 in acute liver injury, and to study the relevant mechanisms. 
Hoping to enrich the new theory, to provide new methods for the diagnosis and 
treatment of acute liver injury. 
Methods 
We chose C57BL/6 mice as experimental mice. IL-6 recombinant protein was 
pretreated ahead. LPS/D-GalN together intraperitoneal injection was used to induce 
acute liver injury model in mice. Then we collected plasma and liver tissues at 
different time windows (2h, 6h). We observed the hepatic histological changesusing 
the HE staining assay in each group. We used microplate method to detect plasma 
alanine aminotransferase (ALT) and aspartate aminotransferase (AST) levels in each 
group. We detected mRNA expression of inflammatory factors in liver by real time 
PCR, and analyzed the protein expression levels of inflammatory cytokines by 
enzyme-linked immunosorbent assay (ELISA). We determined the triglyceride 
content in the liver by a TG enzymic method. 
After pretreatment with IL-6, we used different concentrations of LPS to 
stimulate primary hepatocytes, RAW264.7 and primary macrophages. We used 
RT-PCR to detect the expression of iNOS, TNF-α, RANTES. We used enzyme-linked 
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immunosorbent assay (ELISA) to detect the expression of inflammatory proteins in 
macrophage culture media. We used the macrophage supernatant to culture the 
primary hepatocytes. We used RT-PCR to detect the differences in mRNA expression 
levels of inflammatory factors. 
Result 
1. We explored the best concentration of intraperitoneal injection of LPS/ 
D-GalN to induce acute injury is LPS (50 μg/kg)/D-GalN (400 mg/kg). 
2. At 6 hours, LPS/D-GalN-induced-group compared to the control group, the 
liver appearance was obvious swelling and congestion, liver index significantly 
increased. In the model group given IL-6 in advance, the liver swollen and congestion 
was less obvious and IL-6 significantly reduced liver index. 
3. At 2 hours, LPS/D-GalN-induced-group compared control group mice, HE 
staining results showed that the liver slightly congestive. There was no significant 
difference between the two groups. At 6 hours, LPS /D-GALN induced severe liver 
injury (liver tissue fragmentation and necrosis, and visible a large number of 
inflammatory cell infiltration). In the model group given IL-6 in advance, liver injury 
reversed. 
4. At the time of 2 hours and 6 hours, LPS/D-GalN-induced-group was 
significantly higher in plasma ALT and AST than that of control group. In the model 
group mice given IL-6 in advance, the levels of ALT and AST in the plasma were 
significantly lower. 
5. At 2 hours and 6 hours, the mRNA and protein expression of M1 inflammatory 
factors significantly increased in the model group. After pretreatment with IL-6, the 
mRNA and protein levels of inflammatory factors were significantly lower. 
6. LPS caused a weak inflammatory response to the liver parenchymal cells. 
After IL-6 pretreatment, there was no significant difference in inflammatory factors 
mRNA. 
7. We used different concentrations of LPS stimulate different macrophages. The 
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mRNA and protein expression of M1 inflammatory factors significantly increased. 
After pretreatment with IL-6, the mRNA and protein expression of M1 inflammatory 
factors decreased significantly. We used a certain concentration of LPS to stimulate 
macrophages.The mRNA expression of inflammatory factors were decreased in a 
dose-dependent manner after pretreatment with different concentration gradient IL-6. 
8. The levels of inflammatory mRNA expression in hepatocytes were increased 
in a dose-dependent manner compared with the supernatant of macrophages cultured 
LPS. After IL-6 pretreatment, the expression of inflammatory mRNA levels decreased 
significantly. 
9. Compared with PBS group, IL-4 or IL-13 stimulated RAW264.7 cells, the 
anti-inflammatory mRNA expression significantly increased. The expression of IL-4R 
and IL-10 mRNA in IL-6 group were significantly higher. 
Conclusion 
We induced acute liver injury by injecting different concentrations of LPS and 
D-GalN in C57BL/6 mice at different time points (2h, 6h), and identified the optimal 
dose. Basis on this model, IL-6 pretreatment significantly relieved 
LPS/D-GalN-induced acute liver injury in mice, mainly manifested in the reduction of 
liver congestion, the reversal of hepatic lobular structural disorder and the expression 
of ALT and AST in plasma. In the acute liver injury model, the occurrence of 
inflammation plays an important role. LPS stimulate the kupffer cells to promote the 
release of inflammatory factors, which promote liver cell apoptosis and necrosis, and 
ultimately cause liver injury. Our results showed that IL-6 significantly reduced the 
mRNA and protein levels of inflammatory cytokines, and inhibited inflammatory 
response. 
In vitro, we found LPS causing a weak inflammatory response to the liver 
parenchymal cells, and IL-6 did not show a regulatory role on the inflammatory 
response.IL6 inhibited the expression of inflammatory factors induced by LPS in 
macrophages. IL-6 also promoted IL-4 or IL-13-induced macrophage M2-type 
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polarization. LPS pretreatment in macrophage supernatant, caused hepatocellular 
inflammation, and IL-6 and LPS simultaneously pretreated significantly reduced the 
hepatocellular inflammation. This indicated that LPS stimulated macrophages to 
release inflammatory factors, further acting on hepatocytes, leading to the occurrence 
of hepatocellular inflammation, and IL-6 could inhibit hepatocellular inflammation 
development through inhibiting LPS-induced macrophage of M1-type polarization.  
 
Key words：Acute liver injury, Interleukin-6, LPS + D-GalN, macrophage, 
inflammatory factor 
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第一章 前 言 
1 
第一章 前 言 
1 白介素-6 的介绍 
1.1 IL-6 及其跨膜信号传递方式 
IL-6 是在 1985 年作为 B 细胞刺激因子被克隆出来的，这是由 Kishimoto 等
人首先发现的。人类的 IL- 6 基因位于第 7 号染色体,其蛋白质的分子量为 26kDa。
后来世界各地的实验室证实了肝细胞刺激因子和骨髓血细胞分化诱导蛋白都是
IL-6 的活化形式，因此 1986 年 IL-6 才被统一命名为白细胞介素-6。这也正好说
明了 IL-6 生物学功能的多样性。IL-6 是由 184 个氨基酸的糖基化蛋白组成的，
可以由多种细胞类型合成和分泌，包括单核细胞，T 细胞，成纤维细胞和内皮细
胞等其他细胞。 
关于在 IL-6 的跨膜信号传递方式，主要分为以下两种形式：经典传导通路
和反式信号传导通路。经典通路中，IL-6 通过膜结合的 IL-6 受体刺激靶细胞，
其在配体结合时与信号传导受体蛋白 gp130 耦合。 gp130 发生二聚化，导致 Janus
激酶的激活，随后，细胞质内 gp130 的酪氨酸残基的磷酸化。这导致包含有酪氨
酸磷酸酶-2（SHP-2）和激活 ras / raf /有丝分裂原激活蛋白（MAP）激酶（MAPK）
途径的磷酸酶 Src 同源域来参与到其中。此外，磷酸化的信号转导子和转录因子
激活子募集，发生二聚化，随后它们转移到细胞核中并激活靶基因，这个过程需
要靶细胞表达完整的 IL-6 受体（膜型受体 IL-6R 和跨膜信号转导蛋白 gp130）。
而在反式信号通路中，IL-6 与细胞外液中游离的可溶性受体 sIL-6R 结合成
IL-6/sIL-6R 复合体，再与靶细胞表面的 gp130 结合，即可触发下游信号传递，
这类信号通路只需靶细胞表面表达 gp130 就能完成信号传递[1]。 
IL-6 的大多数促炎作用归因于反式信号转导通路，而抗炎和再生信号传导，
包括肝脏的急性期抗菌反应，均由 IL-6 经典传导通路介导。此外，有许多因素，
包括蛋白酶，细胞因子，化学药物和细胞内信号传导途径，能够通过调节 IL-6R
和 gp130 的膜结合和可溶形式的细胞表达从而调控 IL-6 表达。 
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